Immunohistochemical localization of nephrocalcin, a kidney-specific glycoprotein, to renal cell carcinoma - biosynthesis by human renal carcinoma cells in vitro and in vivo

By Michaels E.K.   Ghosh L.   Nakagawa Y.   Netzer M.F.   Vidal P.   Arsenault D.   Ito H.  

Urology, Vol. 52, Iss. 5, 1998-11 ,pp. : 920-924

Elsevier

Access to resources Recommend Favorite

Prospective Antitumor Effects of the Combination of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and Cisplatin Against Esophageal Squamous Cell Carcinoma

By Kondo Kan   Yamasaki Seiji   Inoue Naoya   Sugie Tomoharu   Teratani Naoki   Kan Takatsugu   Shimada Yutaka  

Surgery Today, Vol. 36, Iss. 11, 2006-11 ,pp. : 966-974

Springer Publishing Company

Access to resources Recommend Favorite

Renal cell carcinoma-associated G250 methylation and expression: in vivo and in vitro studies

By Grabmaier K.   de Weijert M.   Uemura H.   Schalken J.   Oosterwijk E.  

Urology, Vol. 60, Iss. 2, 2002-08 ,pp. : 357-362

Elsevier

Access to resources Recommend Favorite

The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients

By Schendel Dolores   Falk C.   Frankenberger B.   Noessner E.   Schleypen J.   Pohla H.  

Der Urologe A, Vol. 43, Iss. 3, 2004-09 ,pp. : 133-135

Springer Publishing Company

Access to resources Recommend Favorite

Suppression of clusterin expression enhanced cisplatin-induced cytotoxicity on renal cell carcinoma cells

By Lee C.-H.   Jin R.J.   Kwak C.   Jeong H.   Park M.S.   Lee N.K.   Lee S.E.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 516-520

Elsevier

Access to resources Recommend Favorite